your market intelligence analyst
Search Results
222 results
Your search is now limited to «Excipients» expert search.
Market Exclusive 08/21/2019 15:07
CARA THERAPEUTICS, INC. (NASDAQ:CARA) Files An 8-K Entry into a Material Definitive AgreementItem 1.01 License Agreement with Enteris Biopharma, Inc. On August 20, 2019, Cara Therapeutics, Inc. (the “Company”) entered into a Non-Exclusive License Agreement (the “License Agreement”) with Enteris Biopharma, Inc. (“Enteris”). to the License Agreement, Enteris granted to the Company a non-exclusive, royalty-bearing license, including […]. .
More from Market Exclusive: 08/21/2019 08:04
Condition : Esophageal Squamous Cell Carcinoma Intervention : Drug: Anlotinib Hydrochloride, Paclitaxel, cisplatin Sponsors : Henan Cancer Hospital; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting.
More from
Business Wire 08/21/2019 08:00
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that results from the Phase IIIb FOCUS study, which examined fremanezumab versus placebo in adult migraine patients who previously experienced inadequate responses to two to four classes of preventive treatments, were published online ahead of print in The Lancet.
More from Business Wire:
Science-Based Medicine 08/19/2019 03:10
The Vaccine Guide is a website and a book by Ashley Everly, a "toxicology consultant" for Health Freedom Idaho. It's been making the rounds in the antivaccine underbelly of social media lately and basically consists of screenshots of cherry picked studies, articles, and web pages, with Everly's highlighting passages to provide an antivaccine spin. It's clever in a way, but also rather lazy. Don't fall for it.
Natural Products INSIDER 08/14/2019 09:52
Contract manufacturers can help supplement brands ensure their products have efficacious doses by optimizing environmental and processing conditions during R&D and manufacturing.
More from Natural Products INSIDER:
FeedNavigator (EU) 08/14/2019 02:37
Journal of Diabetes Research is a peer-reviewed, Open Access journal that publishes research articles, review articles, and clinical studies related to type 1 and type 2 diabetes. The journal welcomes submissions focusing on the epidemiology, etiology, pathogenesis, management, and prevention of diabetes, as well as associated complications, such as diabetic retinopathy, neuropathy and nephropathy.
More from FeedNavigator (EU):
IMPORTANT SAFETY INFORMATION FOR EYLEA® (aflibercept) INJECTION EYLEA® (aflibercept) Injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.
More from Healthcare Sales & Marketing Network:
PR Newswire 08/13/2019 06:45
INDIANAPOLIS, Aug. 13, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today Taltz® (ixekizumab) met the primary and all major secondary endpoints up to week 12 in the Phase 4 IXORA-R study, which evaluated the efficacy and safety of Taltz versus TREMFYA® (guselkumab) in...
More from PR Newswire:
Healio News 08/12/2019 06:00
We evaluated the antimicrobial efficacy and basic safety profile of a newly developed topical preoperative skin antiseptic ZuraGard (Zurex Pharma), which contains isopropyl alcohol as an active ingredient, as well as the functional excipients citric acid, alkyl para-hydroxybenzoates, methylene blue (as a colorant), and purified water,” Crnich and colleagues wrote.
More from Healio News:
Seeking Alpha 08/12/2019 05:05
Avantor, Inc. (NYSE:AVTR) Q2 2019 Earnings Conference Call August 6, 2019 08:30 ET Company Participants Helen O’Donnell - Investor Relations Michael Stubblefiel.
More from Seeking Alpha: 08/07/2019 18:20
(Natural News) The gun-grabbing extreme liberals and “Demoncrats” of the U.S.A. are raging mad at Neal DeGrasse Tyson for calling out the truth in a tweet after the recent mass shootings. Doctors actually killed more people over the weekend than mass shooters, but the media makes people go INSANE over events that aren’t statistically significant....
More from

Chemicals - Agricultural

Chemicals - Industrial

Business Issues

Companies - Public

Companies - Venture Funded

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities


Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications